# Effect of Simvastatin and Ezetimibe on Lipid and Inflammation

> **NCT01103648** · NA · COMPLETED · sponsor: **Federal University of São Paulo** · enrollment: 50 (actual)

## Conditions studied

- Prediabetes
- Hypercholesterolemia
- Inflammation
- Cardiovascular Risk

## Interventions

- **DRUG:** Simvastatin
- **DRUG:** Ezetimibe
- **DRUG:** Combination Simvastatin plus Ezetimibe

## Key facts

- **NCT ID:** NCT01103648
- **Lead sponsor:** Federal University of São Paulo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-06
- **Primary completion:** 2006-05
- **Final completion:** 2007-11
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2010-04-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01103648

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01103648, "Effect of Simvastatin and Ezetimibe on Lipid and Inflammation". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01103648. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*